Opinion|Videos|January 24, 2025
Understanding CRS and ICANS: Real-World Incidence and Key Patient Risk Factors
Panelists discuss how real-world data on the incidence of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) compare with clinical trial findings as well as the most critical patient-related risk factors for developing these toxicities.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do real-world data on the incidence of CRS and ICANS compare with clinical trial findings? (Dr Allan )
- What are the most critical patient-related risk factors for CRS and ICANS? (Dr Graff)
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CMS Final Rule Ends Federal Medicaid, CHIP Funding for Youth Gender-Affirming Care
2
Trump Childhood Vaccine Order: What It Means for Parents and Payers
3
CAR T, Bispecifics Reshape Relapsed Lymphoma Care: Madhav Seshadri, MD
4
Employers With Claims Data Access Take More Cost Action, Survey Finds
5